OP21.05: Sonographic follow-up of unilocular > 5 cm and multilocular ovarian cysts < 7 cm in post-menopausal women: preliminary results

2010 ◽  
Vol 36 (S1) ◽  
pp. 114-114
Author(s):  
F. Leone ◽  
A. Crepaldi ◽  
G. Tosi ◽  
C. Marciante ◽  
I. Cetin
Keyword(s):  
Ovarian Cysts ◽  
Preliminary Results ◽  
Menopausal Women ◽  
Post Menopausal

scholarly journals Takotsubo cardiomyopathy complicating a twin pregnancy at partum

2019 ◽  
Vol 7 (11) ◽  
pp. 4375
Author(s):  
B.V. Nagabhushana Rao ◽  
A. Rekha ◽  
A. Sankar Narayan ◽  
A. Manjusha
Keyword(s):  
Takotsubo Cardiomyopathy ◽  
Twin Pregnancy ◽  
Apical Ballooning ◽  
Left Ventricular ◽  
Left Ventricular Ejection ◽  
Women Authors ◽  
Ventricular Ejection Fraction ◽  
Menopausal Women ◽  
Post Menopausal

Takotsubo cardiomyopathy is a rare syndrome characterized by acute left ventricular dysfunction with regional left ventricular ballooning, mimicking myocardial infarction. This condition is often described in post-menopausal women. Authors present a case in an elderly primi with twin gestation immediately after Cesarean surgery. We discussed her presentation, investigations, diagnosis, management and outcome. 35 year female, a primi with twin pregnancy developed chest pain and shortness of breath immediately after Cesarean surgery. Her Electrocardiograph was abnormal, and Echocardiogram demonstrated abnormal apical ballooning of the left ventricle and severe dysfunction. Cardiac enzymes were elevated and chest skiagram showed pulmonary edema. She was managed in the intensive care unit with oxygen supplementation, diuretics and inotropes. She made an excellent recovery with normalization of left ventricular ejection fraction within 8 days. During the six months follow up, she was asymptomatic and left ventricular function remained normal.

scholarly journals Effect of increased serum 25(OH)D and calcium on structure and function of post-menopausal women: a pilot study

2020 ◽  
Vol 15 (1) ◽  
Author(s):  
H. J. Hillstrom ◽  
R. Soeters ◽  
M. Miranda ◽  
S. I. Backus ◽  
J. Hafer ◽  
...  
Keyword(s):  
Skeletal Muscle ◽  
Muscle Fatigue ◽  
Repeated Measures ◽  
Vastus Lateralis ◽  
Structure And Function ◽  
Muscle Size ◽  
Menopausal Women ◽  
Post Menopausal ◽  
And Function

Abstract Summary The purpose was to determine if increasing serum 25(OH)D and calcium in postmenopausal women increased skeletal muscle size, strength, balance, and functional task performance while decreasing muscle fatigue. PCSA of the vastus lateralis increased and ascent of stairs time decreased after 6 months of increased serum 25(OH)D. Purpose The Institute of Medicine recommends ≥ 20 ng/ml of serum 25-hydroxyvitamin D [25(OH)D] for bone and overall health. Serum 25(OH)D levels have been associated with physical performance, postural sway, and falls. The purpose of this study was to determine if increasing postmenopausal women’s serum 25(OH)D levels from 20–30 ng/ml to 40–50 ng/ml improved skeletal muscle size, strength, balance, and functional performance while decreasing skeletal muscle fatigue. Methods Twenty-six post-menopausal women (60–85 years old) with baseline serum 25(OH)D levels between 20 and 30 ng/ml were recruited. Oral over-the-counter (OTC) vitamin D3 and calcium citrate were prescribed to increase subjects’ serum 25(OH)D to levels between 40 and 50 ng/ml, serum calcium levels above 9.2 mg/dl, and PTH levels below 60 pg/ml, which were confirmed at 6 and 12 weeks. Outcome measures assessed at baseline and 6 months included muscle physiological cross-sectional area (PCSA), muscle strength, postural balance, time to perform functional tasks, and muscle fatigue. Repeated measures comparisons between baseline and follow-up were performed. Results Nineteen subjects completed the study. One individual could not afford the time commitment for the repeated measures. Three individuals did not take their vitamin D as recommended. Two subjects were lost to follow-up (lack of interest), and one did not achieve targeted serum 25(OH)D. Vastus lateralis PCSA increased (p = 0.007) and ascent of stair time decreased (p = 0.042) after 6 months of increasing serum 25(OH)D levels from 20–30 ng/ml to 40–50 ng/ml. Isometric strength was unchanged. Anterior-posterior center of pressure (COP) excursion and COP path length decreased (p < 0.1) albeit non-significantly, suggesting balance may improve from increased serum 25(OH)D and calcium citrate levels. Conclusions Several measures of muscle structure and function were sensitive to elevated serum 25(OH)D and calcium levels indicating that further investigation of this phenomenon in post-menopausal women is warranted.

scholarly journals Hormone therapy protects from diabetes: the Kuopio osteoporosis risk factor and prevention study

2009 ◽  
Vol 160 (6) ◽  
pp. 979-983 ◽  
Author(s):  
Kati Pentti ◽  
Marjo T Tuppurainen ◽  
Risto Honkanen ◽  
Lorenzo Sandini ◽  
Heikki Kröger ◽  
...  
Keyword(s):  
Risk Factor ◽  
Hormone Therapy ◽  
Social Insurance ◽  
Proportional Hazards ◽  
Population Based ◽  
Prevention Study ◽  
Menopausal Women ◽  
Post Menopausal ◽  
Osteoporosis Risk

ObjectivesThe purpose of this population-based prospective cohort study was to examine the effect of hormone therapy (HT) on incidence of diabetes mellitus (DM).Design and methodsEight thousand four hundred and eighty-three DM-free post-menopausal women aged 52–62 from the population-based Kuopio osteoporosis risk factor and prevention study were followed for 5 years from 1994–1999. Information about the use of HT and health events was obtained from three repeated questionnaires in 1989, 1994, and 1999. DM morbidity before and during the follow-up was obtained from the Registry of Specially Refunded Drugs of the Finnish Social Insurance Institution. Kaplan–Meyer survival curves and Cox's proportional-hazards models were used to estimate the risk of incident DM in relation to the use of HT.ResultsDuring the follow-up, 40.8% DM-free post-menopausal women had never used HT, 27.3% women were HT past users and 31.9% women had used HT presently during the follow-up. During the follow-up, 162 incident DM cases were recorded. Compared with never users of HT, the adjusted hazard ratio of DM was 0.81 (95% confidence interval (CI) 0.57–1.16) for only past users, 0.53 (95% CI 0.24–1.15) in part-time (during the follow-up <2.5 years) users and 0.31 (95% CI 0.16–0.60) in continuous (during the follow-up 2.5–5.0 years) users of HT.ConclusionsHT use decreases the incidence of DM in post-menopausal women.

Sign in / Sign up

Export Citation Format

Share Document